SEC Form 4 · accession 0001209191-17-003085
Epizyme, Inc. · EPZM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew E. Singer
Officer — EVP & CFO
Period of report
Jan 9, 2017
Accepted (ET)
Jan 10, 2017 · 2:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001571498
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.0001F1 | Jan 9, 2017 | M | 1,682 | — | A | 33,506 | D | |
| Common stock, par value $0.0001F1 | Jan 9, 2017 | M | 777 | — | A | 34,283 | D | |
| Common stock, par value $0.0001F3 | Jan 9, 2017 | S | 1,013 | $12.0379 | D | 33,270 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF4 | $0.00 | Jan 9, 2017 | M | 1,682 | D | — | — | Common Stock | 1,682 | 42,047 | D |
| Restricted Stock UnitsF5 | $0.00 | Jan 9, 2017 | M | 777 | D | — | — | Common Stock | 777 | 19,434 | D |
Explanation of responses
- F1Each restricted stock unit represents the contingent right to receive one share of Epizyme, Inc. common stock upon vesting.
- F2The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person to cover taxes associated with the vesting of his restricted stock.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 per share to $12.30 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4This award, granted on February 9, 2016, pursuant to the Company's 2013 Stock Incentive plan, vests as to 25% of the total award on February 9, 2016, a year from the commencement of employment, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter. Vested shares will be delivered to the reporting person.
- F5This award, granted on February 9, 2015, pursuant to the Company's 2013 Stock Inventive Plan, vests as to 25% of the total award on February 9, 2016, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter. Vested shares will be delivered to the reporting person.